Drug Information Analysis Service

Muller P Seeman P . Effect of long-term neuroleptic treatment on neurotransmitter receptors: Relation to tardive dyskinesia. In: Fann WE , ed. Tardive dyskinesia: Research and treatment. New York: SP Medical and Scientific Books, 1980:115–25.

Kane JM Woerner M Borenstein M Wegner J Lieberman J . Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol Bull 1986; 22:254–8.

Schmiedt D . Tardive dyskinesia: Monitoring the patient. US Pharmacist 1991; 16 (12):H3–24.

Richardson MA Pass R Craig TJ Vickers E . Factors influencing the prevalence and severity of tardive dyskinesia. Psychopharmacol Bull 1984; 20:33–7.

Hardeep S Simpson GM . Tardive dyskinesia: Clinical features. In: Wolf M Mosnaim AD , eds. Tardive dyskinesia: Biological mechanisms and clinical aspects. 1st ed. Washington, DC: American Psychiatric Press, 1988:69–86.

Klawans HL Tanner CM Barr A . The reversibility of “permanent” tardive dyskinesia. Clin Neuropharmacol 1984; 7:153–9.

Smith RC . Is the dopaminergic supersensitivity theory of tardive dyskinesia valid? In: Wolf M Mosnaim AD , eds. Tardive dyskinesia: Biological mechanisms and clinical aspects. 1st ed. Washington, DC: American Psychiatric Press, 1988:3–21.

Thaker GK Ferraro TN Hare TA Tamminga CA . Pathophysiology and therapy of tardive dyskinesia: The GABA connection. In: Wolf M Mosnaim AD , eds. Tardive dyskinesia: Biological mechanisms and clinical aspects. 1st ed. Washington, DC: American Psychiatric Press, 1988: 199–215.

Cadet JL Lohr JB . Possible involvement of free radicals in neuroleptic-induced movement disorders: Evidence from treatment of tardive dyskinesia with vitamin E. Ann N Y Acad Sci 1989; 570:176–85.

Ivey M Elmer G . Nutritional supplement, mineral, and vitamin products. In: Penna RP , ed. 7th ed. Handbook of nonprescription drugs. Washington, DC: American Pharmaceutical Association, 1982:221–2.

Cotran RS Kumar V Robbins SL . Nutritional disease. In: Staff WB Saunders , eds. Robbins pathologic basis of disease. 4th ed. Philadelphia: WB Saunders, 1989:447.

Collier DS Berg MJ Fincham RW . Parkinsonism treatment: Part III—update. Ann Pharmacother 1992; 26:227–33.

Lohr JB Cadet JL Lohr MA Larson L Wasli E Wade L , Vitamin E in the treatment of tardive dyskinesia: The possible involvement of free radical mechanisms. Schizophr Bull 1988; 14:291–6.

Lohr JB Cadet JL Lohr MA Jeste DV Wyatt RJ . Alpha-tocopherol in tardive dyskinesia. Lancet 1987; 1:213–4.

Elkashef AM Ruskin PE Bacher N Barrett D . Vitamin E in the treatment of tardive dyskinesia. Am J Psychiatry 1990; 147:505–6.

Shriqui CL Bradwejn J Annable L Jones BD . Vitamin E in the treatment of tardive dyskinesia: A double-blind placebo-controlled study. Am J Psychiatry 1992; 149:391–3.

Egan MF Hyde TM Albers GW Elkashef A Alexander RC Reeve A , Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry 1992; 149:773–7.